February 18th, 2014|
February 18, 2014
Drug manufacturers have a responsibility to ensure the safety of medications they release to the market. Failure to do so can result in patients suffering serious harm, which can lead to lawsuits being filed against the drug maker for damages.
Such a case has been filed in connection to patients suffering a specific Pradaxa Drug Injury, allegedly because the company who made the product failed to warn consumers of certain risks associated with the drug. Now, court documents are showing research that showed the dangers of Pradaxa may have been withheld due to the fact it could harm the marketability of the drug.
An article from the New York Times states the medication was one of several drugs looking to fill a gap in the market for medications used to prevent blood clots from forming in the body. The manufacturer stated it was a better blood clot treatment, as it did not require constant monitoring of blood levels to ensure proper levels of the drugs were being absorbed into the body.
The medication was distributed to 850,000 patients and resulted in an estimated 1,000 deaths due to a risk of uncontrollable bleeding associated with the drug. Lawsuits were filed in connection to the accidents.
Now, court documents are showing researchers may have knew about the dangers, but drug manufacturer executives may have hidden the results. The company has denied the allegations.
The Drug Injury Attorneys with Ferrer, Poirot & Wansbrough recognize the dangers posed by drug manufacturers withholding vital information about a product and are here to help anyone who has been harmed as the result of taking a medication prescribed by a doctor.
November 20th, 2012|
November 20, 2012
Drug manufacturer, Boehringer Ingelheim Pharmaceuticals, Inc., recently issued a voluntary recall on one of its medications due to a packaging defect that could affect the quality of the medication and could lead to a drug injury. According to Packaging World, only one lot of the medication was affected.
Reports indicate that lot 201900 of the medication, Pradaxa®, may have been damaged allowing moisture in. This can cause the active ingredient in the medication to degrade and patients to not receive full doses. Considering the medication is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF), not receiving a full dose of medication could cause patients to suffer serious adverse health events.
Patients who may be in possession of an affected bottle of Pradaxa have been instructed to continue to take their medications as directed until a replacement bottle can be procured. Pharmacists who received part of the affected lot have been instructed to contact patients who may have received the defective products as well.
The Drug Injury Lawyers with Ferrer, Poirot & Wansbrough understand drug distributors and manufacturers have a responsibility to ensure the safety of those who use their product and failure to do so could be considered negligence. This is why the firm would encourage anyone who has been harmed by taking a medication prescribed to you by a doctor to contact an attorney immediately.
July 31st, 2012|
July 31, 2012
According to Injury Lawyer News, a new study is raising concerns that Pradaxa, an anticoagulant medication, could be responsible for causing dangerous internal bleeding to occur in patients taking the medication.
The drug went onto the market in October of 2010 and within the first six-months had received nearly 1,000 claims of adverse events reported to the Food and Drug Administration. Most of the events were related to internal bleeding, while others blamed the medication for strokes and, in some cases, death.
The reports to the FDA were believed by many experts to only be the tip of the iceberg when it came to the number of negative reactions to the drug, leading to a study being performed by the Institute of Safe Medicine Practices (ISMP). Their researchers found that over a one-year period in 2011, a total of 3,781 reports of Pradaxa injuries were made. Of those reports 2, 367 were associated with bleeding, while 644 involved a stroke and 291 claimed renal failure. A total of 542 deaths were also associated with the drug during that time.
The drug injury lawyers with Ferrer, Poirot and Wansbrough would advise patients to become fully educated on the medications prescribed to you by your doctor before beginning to take a regimen of the drug. If you have any questions, they should also be addressed with your doctor or pharmacist before taking the first dose.